{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:43:49Z","timestamp":1782755029923,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijregi.2026.100905","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:49:24Z","timestamp":1776815364000},"page":"100905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment outcomes and associated factors among patients with drug-resistant tuberculosis in Ethiopia: A retrospective cohort study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-0689","authenticated-orcid":false,"given":"Abenezer Abraham","family":"Anito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemechis","family":"Abdissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohannis","family":"Gezahegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim Umer","family":"Muhammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunde","family":"Lemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2026.100905_bib0001","unstructured":"Tuberculosis: multidrug-resistant (MDR-TB) or rifampicin-resistant TB (RR-TB) World Health Organization, https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb); n.d. [accessed 1 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0002","unstructured":"Drug-resistant TB. World Health Organization, https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025\/tb-disease-burden\/1-3-drug-resistant-tb; n.d. [accessed 1 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0003","unstructured":"Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. World Health Organization, https:\/\/www.who.int\/publications\/i\/item\/9789241514842; n.d. [accessed 1 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0004","unstructured":"Drug-resistant TB treatment. World Health Organization, https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024\/tb-diagnosis-and-treatment\/2-4-drug-resistant-tb-treatment; n.d. [accessed 1 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0005","article-title":"Strengthening the global Response to tuberculosis: insights from the 2024 WHO global TB report","volume":"39","author":"Estaji","year":"2025","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","article-title":"Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019","volume":"24","author":"Lv","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0007","unstructured":"Guidelines for Clinical and Programmatic Management of TB, TB\/HIV, DR-TB and Leprosy in Ethiopia \u2013 TRAC, https:\/\/traceth.net\/guidelines-for-clinical-and-programmatic-management-of-tb-tb-hiv-dr-tb-and-leprosy-in-ethiopia\/; n.d. [accessed 1 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0008","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1186\/s12879-024-10205-6","article-title":"Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Southwestern Oromia, Ethiopia: ten-year retrospective analysis","volume":"24","author":"Bonsa","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0009","unstructured":"Ethiopia launches programmatic introduction of the 6-month BPaLM\/BPaL regimen for RR\/DR-TB treatment. TRAC, https:\/\/traceth.net\/ethiopia-launches-programmatic-introduction-of-the-6-month-bpalm-bpal-regimen-for-rr-dr-tb-treatment\/; n.d. [accessed 5 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262318","article-title":"Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia","volume":"17","author":"Wakjira","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100905_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040862","article-title":"National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study","volume":"11","author":"Tola","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijregi.2026.100905_bib0012","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/IDR.S365394","article-title":"Multidrug-resistant tuberculosis treatment outcome and associated factors at the university of Gondar comprehensive specialized hospital: a ten-year retrospective study","volume":"15","author":"Belachew","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijregi.2026.100905_bib0013","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/s12879-024-09745-8","article-title":"Treatment outcomes of standardized injectable shorter regimen for multi-drugs resistant tuberculosis in Ethiopia: a retrospective cohort study","volume":"24","author":"Achalu","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224025","article-title":"Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia","volume":"14","author":"Woldeyohannes","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100905_bib0015","unstructured":"The end TB strategy. World Health Organization, https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/the-end-tb-strategy; n.d. [accessed 2 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0016","unstructured":"Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions. World Health Organization, https:\/\/www.who.int\/publications\/i\/item\/9789240022195; n.d. [accessed 2 February 2026]."},{"key":"10.1016\/j.ijregi.2026.100905_bib0017","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/cid\/cix667","article-title":"Factors associated with all-cause mortality among patients with multidrug-resistant tuberculosis-United States, 1993-2013","volume":"65","author":"Salinas","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12879-017-2230-2","article-title":"Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine","volume":"17","author":"Aibana","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0019","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12889-017-4216-9","article-title":"Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences","volume":"17","author":"de Vries","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijregi.2026.100905_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250028","article-title":"Evaluation of drug-resistant tuberculosis treatment outcome in Portugal, 2000\u20132016","volume":"16","author":"Oliveira","year":"2021","journal-title":"PLOS One"},{"key":"10.1016\/j.ijregi.2026.100905_bib0021","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cmi.2017.07.008","article-title":"Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009\u20132013","volume":"24","author":"Zhang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijregi.2026.100905_bib0022","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.3346\/jkms.2023.38.e33","article-title":"Nationwide treatment outcomes of patients with multidrug\/rifampin-resistant tuberculosis in Korea, 2011\u20132017: a retrospective cohort study (Korean TB-POST)","volume":"38","author":"Choi","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijregi.2026.100905_bib0023","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jfma.2015.10.002","article-title":"Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt","volume":"115","author":"Gadallah","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.ijregi.2026.100905_bib0024","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.5588\/ijtld.15.0915","article-title":"Treatment outcomes of drug-resistant tuberculosis patients in Kenya","volume":"20","author":"Mibei","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijregi.2026.100905_bib0025","doi-asserted-by":"crossref","first-page":"dlaa108","DOI":"10.1093\/jacamr\/dlaa108","article-title":"Clinical characteristics and treatment outcomes of patients with MDR tuberculosis in Dar es Salaam region","volume":"2","author":"Myemba","year":"2020","journal-title":"Tanzania. JAC Antimicrob Resist"},{"key":"10.1016\/j.ijregi.2026.100905_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241684","article-title":"Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study","volume":"15","author":"Bade","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2026.100905_bib0027","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1017\/S0950268820002514","article-title":"Predictors of mortality among multidrug-resistant tuberculosis patients in central Ethiopia: a retrospective follow-up study","volume":"148","author":"Kassa","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijregi.2026.100905_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6696199","article-title":"Survival status and predictors of mortality among multidrug-resistant tuberculosis patients in Saint Peter's Specialized Hospital, Addis Ababa, Ethiopia","volume":"2021","author":"Muluneh","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707626000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:45:04Z","timestamp":1782751504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707626000688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S2772707626000688"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100905","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment outcomes and associated factors among patients with drug-resistant tuberculosis in Ethiopia: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2026.100905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100905"}}